Arkolith/Insider Trading/AVBP/Form 4

HHLR Advisors, LTD.

10% OwnerArriVent Biopharma, Inc. (AVBP) · full profile →Form 4 · filed Feb 1, 2024
Net Buying
Open-Market Buys
$10.0M
Open-Market Sells
$0
Net Open-Market Flow
$10.0M
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 30, 2024Conversion(C)313K——3.9M
Jan 30, 2024Buy(P)556K$18.00$10.0M4.5M
Jan 30, 2024Conversion(C)3.6M——3.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 30, 2024Conversion(C)55.0M—$00
Jan 30, 2024Conversion(C)4.8M—$00

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000902664-24-000903) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML